Media Advisory and Statement from Onego Bio Regarding Jurisdiction Update from May 5th
Onego Bio welcomes the selection of Delaware as the jurisdiction to resolve patent litigation against EVERY
On May 5th, the judge in Wisconsin ruled that Delaware is the appropriate location for Onego’s claims against EVERY to proceed. The judge said that his decision is purely jurisdictional. Now that this important procedural first step has been taken, the case is now fully focused in the premier location for IP litigation.
As a summary, the goal of this litigation is to remove invalid patents from the marketplace so that all companies in the space can innovate fairly, transparently, and without the threat and fear of artificial monopolies. The language from the filing illustrates as much: “Onego contends that EVERY is attempting to enforce the ‘784 patent, so Onego is seeking a declaration that it does not infringe the ‘784 patent and that the patent is invalid.”
All of Onego’s claims remain entirely intact and the business of litigating will now begin. Onego purposely filed for applications in two locations. Both are appropriate locations and were proposed for different reasons:
Delaware: Both companies are incorporated is Delaware, where personal jurisdiction is not an issue. Additionally, Delaware is the premier location for IP litigation and the country's leading forum for complex biotech patent disputes.
Wisconsin: As this will be the home of Onego’s first manufacturing site, it was a natural selection for the company to make an initial filing application.
As both companies are incorporated in Delaware, each will now be obligated to fully participate in discovery. The case is not finished, but only just beginning.
Furthermore, and as anticipated, significant progress was made in the initial discovery in Wisconsin. Onego learned and confirmed some very important facts which identified strong evidence to support Onego’s claims—all of which are now publicly available and will be used in Delaware.
Maija Itkonen, Onego Bio co-founder and CEO also shared the following statement: “Our products are built on a solid foundation and originate from one of the most trusted innovation ecosystems in the world. We believe markets thrive through open competition, where lasting value comes from genuine performance, long-term scientific research, and transparent business practices.
We also believe in a world where integrity is a core value. One where progress is not achieved by distorting facts, manipulating others’ words, or avoiding responsibility, but by facing situations as they are and addressing them directly and responsibly. The standards we choose to uphold define the system we operate within.
For that reason, when obstacles arise that risk distorting this balance, we are compelled to act to ensure the market remains open and fair, operating with integrity.”